DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Customers Whose Personal Data May Have Been Compromised By the PharMerica Data Breach
NEWTOWN, PA — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by PharMerica Corporation (“PharMerica” or the “Company”) resulting from a data breach that occurred between March 12 and March 13, 2023. The Company learned of suspicious activity on March 14, 2023, but failed to notify customers until May 12, 2023. The data breach affected over 5.8 million individuals.
Background on PharMerica
PharMerica, based in Louisville, Kentucky, is a pharmacy services provider in 50 U.S. states, operating 180 local and 70,000 backup pharmacies, and serving 3,100 medical facilities nationwide.
What happened?
On March 14, 2023, the Company was alerted about a potential data breach. After completing an internal investigation on March 21, 2023, the Company determined that client information had been stolen between March 12 and March 13, 2023. A ransomware group claimed the attack on March 28, 2023, when they began publishing stolen data.
How can I protect my personal data?
Edelson Lechtzin LLP is investigating bringing a class action lawsuit to seek legal remedies on behalf of customers who may have had their sensitive personal and patient data compromised by the PharMerica data breach.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Web: www.edelson-law.com
About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.